T1	Participants 71 137	patients having coronary stent implantation treated with prasugrel
T2	Participants 211 295	patients with acute coronary syndromes undergoing percutaneous coronary intervention
T3	Participants 441 485	"real-world" patients treated with prasugrel
T4	Participants 1037 1087	Patients ≥75 years old and with body weight ≤60 kg
